CNTO4088 is a highly specialized monoclonal antibody target the human interleukin-23 cytokine with exceptional binding affinity and selectivity, neutralization of the p19 subunit-mediated biological activities across various preclinical experimental models of autoimmune inflammation to evaluate the functional role of the Th17 signaling axis in pathological tissue remodeling during strictly monitored laboratory observation periods.
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted
